argenx SE, a biotechnology company established in Amsterdam, the Netherlands, in 2008, is dedicated to developing innovative therapies primarily for autoimmune diseases.
Argenx Se stock last closed at $856.94, down 2.18% from the previous day, and has increased 32.53% in one year. It has overperformed other stocks in the Biotechnology industry by 0.45 percentage points. Argenx Se stock is currently +32.82% from its 52-week low of $645.17, and -10.13% from its 52-week high of $953.58.
As of Aug 13, 2026, there are 62.54M ARGX shares outstanding. The market value of ARGX is $53.59B. In the past 24 hours, 170,000 ARGX shares were traded.
How to Buy Argenx Se Stock
Wondering how to invest in Argenx Se stock? Here's how.
Figure out where to buy Argenx Se stock: You need to choose an online brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you choose where to buy Argenx Se stock.
Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
Deposit funds into your investment account: Select your method of payment and add your details.
Research Argenx Se stock: The Argenx Se ticker symbol is ARGX. Is Argenx Se stock a good investment? Should you buy shares of ARGX? How do ARGX's underlying business fundamentals look? Do top analysts think Argenx Se is a good buy? Why has ARGX's stock price moved recently? (Hint: Our stock research tools can help you figure out if ARGX is a good stock to buy).
Execute your ARGX trade: Decide if you will purchase ARGX shares at the current market price or use a limit order to buy ARGX shares at a specific price.
Monitor your investment in ARGX: Create a watchlist to important notifications about your new investment in Argenx Se stock.
Step 1: Figure out where to buy Argenx Se stock
You need a brokerage account in order to access the NASDAQ market and buy ARGX shares.
A brokerage account is an investment account that allows you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
In our opinion, eToro is the best place to buy stocks. Here's why:
Invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to global markets: From Technology to Energy, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by opening an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've selected your brokerage, the next step is to fill out some personal information so you are able to invest in ARGX today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Argenx Se stock
After you have decided on the best place to buy Argenx Se stock, it's very important to evaluate their stock before you invest, so you truly wrap your head around the risk as well as the opportunity.
Argenx Se stock at a glance
ARGX Price
$856.94
1w %
-2.1%
1y %
32.53%
5y %
175.53%
P/E
27.18x
P/B
5.6x
P/S
N/A
PEG
1.43x
Revenue
$0.00
Earnings
$1.95B
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$53.59B
Next Earnings
N/A
Next Dividend
N/A
Argenx Se Overview
WallStreetZen was built to help part-time investors do better fundamental analysis quickly.
ARGX earnings of $1.99B is not sufficient to cover its interest payments.
There are more short-term assets than long-term liabilities on the ARGX balance sheet.
There are more short-term assets than short-term liabilities on the ARGX balance sheet.
ARGX's operating cash flow of $1.11B allows it to safely service it's debt of $53.41M.
ARGX has a low debt to equity ratio of 0.19.
Cons:
Total ARGX debt is higher than 5 years ago, relative to shareholder equity.
Is it a good time to buy ARGX stock, according to Wall Street analysts?
Out of 12 sell side analysts who give forecasts on ARGX, the consensus analyst rating on ARGX is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Latest ARGX Analyst Ratings
Jason N. Butler, a top 18% analyst from Citizens maintains ARGX with a buy rating and lowers their ARGX price target from $944.00 to $932.00, on Jul 24, 2026.
Samantha Semenkow, a top 20% analyst from Citigroup maintains ARGX with a strong buy rating and raises their ARGX price target from $1,152.00 to $1,182.00, on Jul 21, 2026.
Citigroup's Samantha Semenkow raised their price target on Argenx SE (NASDAQ: ARGX) by 2.6% from $1,152 to $1,182 on 2026/07/21. The analyst maintained their Strong Buy rating on the stock.
Semenkow attributed their price target hike on Argenx SE to a higher probability-of-success for the Phase 3 ALKIVIA data in immune-mediated necrotizing myopathy
Positive IMNM data in late 2026/08 or early 2026/09 is highly likely, the analyst added.
Tazeen Ahmad, a top 26% analyst from Bank of America maintains ARGX with a strong buy rating and raises their ARGX price target from $1,016.00 to $1,088.00, on Jul 2, 2026.
Douglas Tsao, a top 2% analyst from HC Wainwright & Co. reiterates ARGX with a buy rating and maintains their ARGX price target from $940.00 to $940.00, on Jun 25, 2026.
Matthew Harrison, a top 20% analyst from Morgan Stanley maintains ARGX with a strong buy rating and raises their ARGX price target from $1,170.00 to $1,180.00, on Jun 24, 2026.
Last year, ARGX earnings were $1.95B. During the past 1 years, ARGX's earnings have gone up by 26.02% per year. This was faster than the Biotechnology industry average of 10.53%.
Last year, ARGX revenue was $0.00. During the last 5 year, ARGX's revenue has increased by -100% per year. This was slower than the Biotechnology industry average of 24.86%.
No, Argenx Se doesn't provide an income stream by paying out dividends.
What do other traders have to say about ARGX?
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Execute your ARGX trade
You have two main types of orders:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are mostly the easiest way to buy.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to ensure you're buying or selling at a particular price, use a limit order.
Click the Open button and eToro will place your order.
If you require more help with buying stocks on eToro, watch the helpful video below:
As of Aug 13, 2026, it costs $856.94 to buy one share of Argenx Se stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.117 shares of ARGX.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.